SEC 13F Intelligence

Tradelink Capital LLC / HAE

Tradelink Capital LLC’s Haemonetics Corp Mass Position

Does Tradelink Capital LLC own Haemonetics Corp Mass (HAE)? Not currently — the last reported position was 14.0K shares worth $1M in Q2 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$1M
Q2 2025
Shares
14.0K
% of Portfolio
+3.69%
Quarters Held
5
position exited

Position History HAE

Reported value by quarter
Q2 ’19: $205,000Q2 ’19Q2 ’24: $400,000Q2 ’24Q4 ’24: $902,000Q4 ’24Q1 ’25: $571,000Q1 ’25Q2 ’25: $1MQ2 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q2 202514.0K$1M+3.69%
Q1 20258.8K$571,000+3.53%
Q4 202411.6K$902,000+8.90%
Q2 20244.8K$400,000+1.15%
Q2 20191.7K$205,000+3.06%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Tradelink Capital LLC’s full portfolio or all institutional holders of HAE.